3 Stocks to Get on Your Watchlist
An exciting oncology-focused biopharma ready to deliver results, a possible bargain-basement price on a deep-sea driller, and a potentially overvalued social-gaming company are today's must-watch stocks.
Ignore the Financials; This Was Zynga's Best Quarter Ever
Revenue improved slightly while users dropped. But Zynga's new acquisition made the fourth quarter report one to remember.
Why Zynga Is Up 40% in 3 Days
Zynga has enjoyed a nice few days. Shares are up considerably after the company reported earnings alongside a promising acquisition, and getting another boost from an analyst upgrade.
A New Look at Zynga's Key Metric
Zynga's key metric has grown again - but at what cost?